Literature review for - Flourish Paediatrics

month) (outcome five). For the 8-12
month period, the results show a
slightly but significantly higher
length gain in the EBF group (WMD
0.9 (95% CI 0.3-1.4)) mm per month
(outcome six). Observational
analyses from the Belarussian study
(Kramer 2000a) also include data on
weight-for-age, length-for-age, and
weight for-length z-scores at 6, 9,
and 12 months. Means in both the
EBF and MBF groups were well
above (+0.5 to +0.6) the reference
values at all three ages. Nonetheless,
the weight-for-age z-score was
slightly but significantly lower in the
EBF group at all three ages: WMD -
0.09 (95% CI -0.16 - -0.02) at six
months, -0.10 (95% CI -0.18 - -0.02)
at 9 months, and -0.09 (95% CI -0.17
to-0.01) at 12 months (outcomes
seven to nine). Length-for-age z
scores were very close to the
reference (0) at 6 and 9 months and
slightly above the reference (0.15) at
12 months. Again, the EBF group
had slightly but significantly (except
at 12 months) lower values: WMD -
0.12 (95% CI -0.20 - -0.04) at 6
months,-0.14 (95% CI -0.22 to -0.06)
at 9 months, and -0.02 (95% CI-0.10
- 0.06) at 12 months (outcomes 10 to
proportional reduction in deaths before
12, 24 and 36 months respectively. The
% of DALYs averted at 36 months was
21.9 million for 99% coverage with
breastfeeding promotion and support.
544